Jordi Remon, Thoracic Oncologist at CIOCC Barcelona, shared on X:
“Treatment landscape of early-stage NSCLC is evolving very fast.
We review current SoC with IO and targeted therapies(TT) and future challenges:
- Neoadj vs periop?
- IO in borderline resectable
- How to increase CR -Role of TT..”
Title: Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges
Authors: Jordi Remon, Tina Cascone, Stephanie P. L. Saw, Nikolaj Frost, Molly S. C. Li, Lizza E. L. Hendriks, Antonin Levy, Alessandro Di Federico, Jamie E. Chaft, Karim Abdelhamid, Mark Awad, Giannis Mountzios, Solange Peters
You can also read: Stage III NSCLC Management 2026: Powerful Advances Transforming Multimodal Care
